February 19, 2016
Fujifilm said on February 18 that it has launched a PI clinical trial in the US for its investigational cancer agent FF-10502 targeting pancreatic cancer and other solid tumors. FF-10502, which blocks tumor growth by inhibiting the DNA synthesis of...read more